WHO combats diseases, aids crises, and embraces AI for global health. By 2025, aims: 1 billion with health coverage.
The FDA has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback